Human synthetic biology enterprise bit.bio will be exhibiting, hosting a workshop and presenting at ELRIG UK’s Drug Discovery 2021, held at ACC Liverpool from October 19-20, 2021.
The company will be exhibiting at booth B16/B9, where visitors are able to learn about bit.bio’s mature, functional human iPSC-derived human cells, ioCells, for disease modelling and drug discovery.
Attendees can watch bit.bio’s talk, “Coding cells for health: Building translational disease models for drug discovery and therapeutics”, on October 19 at 11:30 BST in Hall 1C to learn about its scalable platform capable of producing consistent batches of human cells and how we are applying our technology to build translational disease models to accelerate drug discovery. This talk will highlight the practical applications of next generation cellular reprogramming technology, opti-oxTM.
bit.bio will also host a workshop, “The challenges of cell models: Novel approaches and tools for basic research and drug discovery”, on October 20 at 10:50 BST. From 3D bioprinting to high throughput screening, this workshop will cover how experts in the field are using innovative techniques and tools to address the need for easily accessible, reliable and scalable human cell models for research and drug discovery. It will be hosted by Luckshman Jeremy Anton (Scientist at Charles River Laboratories), Michael Duchen (Professor of Physiology at University College London), and Hagan Bayley (Professor of Chemical Biology at University of Oxford).
